Young adults with ADHD are struggling to access treatment as they transition from children's to adult services, due to poor coordination between services, according to new research. A national survey by the University of Exeter revealed significant inconsistencies in the prescribing and management of ADHD medication in primary care, especially when young people move to adult mental health services. This is despite NICE guidelines recommending shared-care agreements between GPs and adult mental health services for ADHD medication.
Over 40% of respondents reported waiting more than two years for an appointment with adult services, leaving GPs to manage their care. However, many GPs expressed concerns about prescribing ADHD medication without adequate support, citing issues with insurance and liability. This situation is particularly challenging for those with private ADHD diagnoses, leaving some patients without access to vital medication that had been effective during their childhood.
The survey also highlighted that certain underserved groups, such as young women and care leavers, face even greater difficulties in accessing treatment, further exacerbating health inequalities. This lack of coordinated care is increasing the disparity in ADHD treatment across the country.
Dr Anna Price from the University of Exeter stressed the need for a more joined-up approach to support GPs in managing ADHD under shared-care agreements. She emphasised the importance of consistent treatment during the transition to adulthood, particularly at a critical life stage when young people are managing key milestones like exams, university, or starting their careers.
